Rifaximin treatment in hepatic encephalopathy.
Sharma
Praveen
P
Sharma
Barjesh Chander
BC
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D006501:Hepatic Encephalopathy / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications; D010538:Peritonitis / Q000150:complications / Q000517:prevention & control; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D007792:Lactulose; D000078262:Rifaximin